Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

NCT06439888 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Disease
Solid Tumor, Adult

Interventions

DRUG: all-trans retinoic acid
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris